Publication | Closed Access
CEACAM1, a Novel Serum Biomarker for Pancreatic Cancer
160
Citations
34
References
2007
Year
CEACAM1 is expressed in pancreatic adenocarcinoma, and serum levels of CEACAM1 serve as a useful indicator for the presence of pancreatic cancer. Additional validation studies on the use of serum CEACAM1 as a diagnostic marker in pancreatic cancer are warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1